DermTech, Inc. Reports Third Quarter 2019 Financial Results and Provides Corporate Update
LA JOLLA, Calif.–(BUSINESS WIRE)–DermTech, Inc. (NASDAQ: DMTK) (“DermTech” or the “Company”), a leader in precision dermatology enabled by a non-invasive…
Pharmaceuticals, Biotechnology and Life Sciences
LA JOLLA, Calif.–(BUSINESS WIRE)–DermTech, Inc. (NASDAQ: DMTK) (“DermTech” or the “Company”), a leader in precision dermatology enabled by a non-invasive…
AvantGen’s NK cell engager technology now available for partnering on a target-exclusive basis SAN DIEGO–(BUSINESS WIRE)–AvantGen, Inc., a biotechnology company…
BOSTON & LOUISVILLE, Ky.–(BUSINESS WIRE)–Talaris Therapeutics, Inc., a privately held biotechnology company developing transformative cell therapies that have the potential…
KASSEL, Germany & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Targos Molecular Pathology GmbH, a market leader in clinical biomarker services announced today a technology…
TORONTO & SEOUL, South Korea–(BUSINESS WIRE)–#artificialintelligence–Renowned South Korean healthcare company, Yuhan Pharmaceuticals (Yuhan) and Cyclica Inc. (Cyclica), a leading neo…
VANCOUVER, British Columbia–(BUSINESS WIRE)–#antibodies–AbCellera Biologics Inc., a global leader in therapeutic antibody discovery from natural immune systems, today announced that…
Scynexis biotechnology company on Thursday announced positive top-line results for its Phase 3 VANISH-303 study investigating the safety and efficacy of oral ibrexafungerp as a treatment for women with vulvovaginal candidiasis (VVC).
LONDON–(BUSINESS WIRE)–#Biotechnology–Technavio has been monitoring the global vaccines market and the market is poised to grow by USD 13.81 billion…
CEO Patrick Jordan and other biopharmaceutical leaders to discuss industry’s shifting focus on women’s health at Europe’s largest life science…
— Partnership with the Boston-based R&D innovation unit of LEO Pharma A/S advances development of Epicore Biosystems’ wearable Discovery patch…